We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Personalised Co. is a nutrition company on a mission to help as many people as possible reach their health and wellbeing goals by making supplements accessible and affordable. The company asserts that it provides personalised nutritional products to its consumers. Customers are required to take a quiz on the company's portal, based on which, the company's custom-built algorithm creates nutritionist-approved solutions tailored to the specific needs and goals of each customer. Personalised Co. has delivered 270,000 daily vitamin sachets till date. The company has also raised £192,000 from private investors and its first crowdfunding campaign in 2019. It achieved its milestone month in April 2020 earning £48,000 in revenue and delivering over 1,700 personalised vitamins and protein orders. The company will use the investment to level-up its operations, expand its product line and develop its companion-application.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £401,417
Spotlight Consultations aims to diagnose diseases based on evidence-based questionnaires. The company's Algorithmic Questionnaire (AQ) strives to be a simple 3-5 minute questionnaire, dynamically responsive with each question linked to an actionable care pathway. The company estimates that 10% of global health expenditure per annum is spent on diabetes, which is predicted to rise to $825 billion by 2030. Indirect costs from premature death, disability, and diabetes-related health complications add an additional 35% more to this number. Spotlight intends for its AQ to help reduce expenditure and healthcare burden while improving the quality of care and health outcomes. The company will use the investment to support early revenue generation, team expansion and stimulate Research and Development (R&D) tools to cover more diseases like CVD, IBD, chronic pain, and cancers.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £69,682
Moody is a health-tracking application that connects users with customised health, food and fitness advice based on their moods, symptoms and cycles. It endeavours to become a sustainable force for good in women's health. The company argues that women control >80% of household health spend and are 80% more likely than men to use a digital health app. It aims to harness these trends and capitalise on the global remote health care market that is forecast to hit £40 billion by 2025. 'The Moody Month' app featured in publications like Vogue, Grazia and The Guardian. It has witnessed over 136,000 downloads since its Version 1 release in 2019. The app has compiled over 5 million moods to date. The company will use the investment to scale its business globally and reach 1 million subscribers within a four-year time frame.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £142,026
Sendit.Money is a remittance entity. It argues that individuals sending or receiving money in emerging markets can face insecure processes, slow transaction times and incur high costs. Sendit.Money asserts that this is because non-fiat currencies are changed multiple times before they are received. The company aims to change this. Its prototype application for African markets was received amidst positive feedback. It is now building a cost-effective mobile wallet providing a secure and inexpensive way to send and receive money that also allows users to compare transfer fees of different remittance agents in real-time. Sendit.Money was shortlisted as Best Global start-up at the 2020 Wales Startup Awards. The company will build and launch its Most Valuable Product (MVP) in Q3 of 2021. It will also use the funding to begin work with an authorised entity to become an approved representative.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £182,732
Whatbook is a book discovery and social network app for readers. Its goal is to become the go-to platform for everything book related and ultimately to get people reading more. The company's app is live on iOS and Android with 8,000+ users growing daily. It saved up to £3,000 by shooting its campaign video at home due to COVID-19 and put that into developing new features for its app. Whatbook aims to become a segment leader in the projected $100 billion book industry and work with publishers and booksellers on the most effective route to success and getting more people reading. The company will use the investment for marketing and platform development.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £255,374
Wirex is a UK financial technology company that aims to bring crypto & fiat currencies together on one simple payments portal. The company is building a platform where buying, holding, saving and spending any digital and traditional currency is quick, easy and accessible. The Wirex app supports 12 fiat and 10 crypto currencies, operates in 130 countries, and has more than 3.1 million registered users. Wirex launched the first Visa crypto-enabled payments card in the world. It has a £3 billion cumulative transaction volume and plans to expand to the USA by end-2020. Wirex will use the investment to allow millions of its users to own a share of the brand.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £3,703,120
Ayoa by OpenGenius is an intelligent digital workspace for remote teams to manage meetings, build plans and action tasks. Launched in June 2019, Ayoa already has over 12,000 paying users and c. 300,000 users who have signed up for the free product. Ayoa is used by many people at reputable organisations such as the BBC, Ernst & Young, and Cambridge University. It has an average customer rating of 4.5 stars from 1,000+ reviews across the Apple App Store, Google Play and Capterra. Moreover, the company's CEO, Chris Griffiths, has been featured in several publications such as the BBC, The Times, Forbes, GQ, and The Telegraph as an expert on topics such as creativity and productivity. With the funds received, the company will further develop its product by releasing newer features such as Smart Meetings, and Intelligent Digital Workspace, smoothening powerful integrations and integrating AI tools into the application.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,143,029
GeoDB is a decentralised peer-to-peer big data-sharing ecosystem, powered by Blockchain Technology, which rewards you for data generated. Users upload their data to the ecosystem and in exchange get rewarded for the data generated and datasets are purchased by buyers to access the data pool. It aims to solve the existing inefficiencies of the data industry. Till now, the company has launched Data Generator Network and Data Generator App GeoCash. The company has secured partnerships with five big data companies from Europe & Latin America. Their app is available on the google play store. Also, they have over 15,000 social media followers, including Telegram, Wechat, Twitter, Linkedin, and Medium. The proceeds will be spent on team building, marketing and growth of their Token to increase its visibility and presence in more significant and liquid exchanges.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,527,399
Grow is a British biopharmaceutical company on a mission to unlock the potential of cannabis medicines for patients globally. It claims that it is one of the largest importers of cannabis medicines in the UK and Ireland since its founding in 2017. The company has raised over £9.5 million through several fundraising rounds to allow expansion of operations, supplied medicines to more than 1,200 patients a month as of June 2021, and earned £2.35 million in revenue as of July 20, 2021. The company has also launched its patient app, Calyx, to help patients track their medications and health indicators and signed long term partnerships with some of the world’s leading cannabis companies, including Aurora, Tilray and Columbia Care. The company argues that it has also pioneered the ‘Open Cannabis’ campaign to improve education on cannabis medicines and the means to access them in the UK. It states it will use 40% of the investment on capital expenditure, 30% on hiring new personnel, and 30% as working capital.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £3,566,133
Swipii connects users to local brick-and-mortar businesses in their vicinity via its app. It allows users to earn cashback on every transaction done through the app via a debit/credit card and allows local businesses to reach more customers and run their business profitably. Swipii has 26,500 registered users on its platform and has witnessed £440,000 spent at 212 businesses nationwide. The company argues that despite the COVID lockdown, 33% of Swipii users made >1 cashback transaction each month in 2020. It aims to become a contender in the £60 billion global cashback market. Swipii has featured in The Guardian, BBC, and Wired. It won the 2016 UK Digital Experience Awards and its founders were mentioned in Forbes '30 under 30' winners. The company will use the investment to scale up user and business acquisition in new cities across the UK before going global.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £921,643
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph